News

Filter

Current filters:

ReproductiveRare diseases

US NDA filings for Vivus’ ED drug avanafil and Corcept’s Corlux for Cushing’s

01-07-2011

California, USA-based Vivus (Nasdaq: VVUS) has submitted a New Drug Application has to the Food and Drug…

avanafilCorluxNorth AmericaPharmaceuticalRare diseasesRegulationReproductiveVivus

US FDA approves CSL Behring’s Corifact; warns on pre-term use of terbutaline

18-02-2011

The US Food and Drug Administration has approved Corifact, the first product intended to prevent bleeding…

CorifactCSL BehringGenericsNorth AmericaPharmaceuticalRare diseasesRegulationReproductiveRespiratory and Pulmonaryterbutaline

COMPANY SPOTLIGHT

Menarini

Back to top